Nagoya University Hospital - Department of Neurology

Number of service categories this organization offers.

• ✓1 service category listed

PubMed publications + ClinicalTrials.gov active trials linked to this organization.

• —0 PubMed publications
• —0 active clinical trials

How easy it is for patients and families to reach this organization.

• ✓Has website
• ✓Has phone number
• ✓Has email
• ✓Has street address
• ✓Has map coordinates

Breadth of direct support offered to patients and families.

• —In-person support groups
• —Online support groups
• —Caregiver resources in services
• —Funds or provides home care
• —Children's resources

Percentage of profile fields with information.

• ✓Name
• ✓Type
• ✓Country
• ✓State / region
• ✓Address
• ✓Phone
• ✓Email
• ✓Website
• ✓Mission

Connections to research consortia and ALS networks.

• —Part of a consortia
• —International reach
• —Publishes research
• —Maintains an ALS database
• —Mentions a known network (NEALS, ENCALS, TRICALS, etc.)

No community reviews yet — this dimension is excluded from the overall score.

• —No reviews yet

Contact

Mission

Lead: Prof. Gen Sobue. Japan's flagship ALS research and clinical center; lead institution of the Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS); one of the world's most prolific ALS research programs. Lead: **Professor Koji Yamanaka, PhD** — internationally-recognized ALS basic science researcher; co-author with Don Cleveland (UCSD) on landmark 2008 paper in Nature Neuroscience establishing astrocytes as disease progression determinants in inherited ALS; TDP-43 monomerization and microglial heterogeneity ALS research. Flagship hospital in the Tokai area of Japan — central Japanese ALS referral center Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS) — Nagoya-coordinated national ALS research consortium; foundational publications include Nakamura R et al. "Genetic factors affecting survival in Japanese patients with sporadic ALS: genome-wide association study and verification in iPSC-derived motor neurons from patients" (J Neurol Neurosurg Psychiatry 94: 816-824, 2023) — landmark JaCALS GWAS Randomized Phase 2 study of perampanel for sporadic ALS — Aizawa H et al. (J Neurol 269: 885-896, 2022) — Japanese multicenter trial Yamanaka Lab ALS research: TDP-43 monomerization (Oiwa K et al., Science Advances 2023), mutant SOD1 in non-motor-neuron cell types (Yamanaka K et al., Nature Neuroscience 2008), microglial heterogeneity in ALS (iScience 2024), astrocyte-derived TGF-β1 disease progression (Cell Rep 2015) AMED-LEAP, JST MOONSHOT R&D Program grants — major Japanese national research funding